Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ligand-gated calcium channel activity	TRPM2 ITPR1 ITPR2 TRPM8	3.91e-05	31	124	4	GO:0099604
GeneOntologyMolecularFunction	inositol 1,4,5-trisphosphate-gated calcium channel activity	ITPR1 ITPR2	1.14e-04	3	124	2	GO:0005220
GeneOntologyMolecularFunction	histone H2AXS139 kinase activity	ATR PRKDC	1.14e-04	3	124	2	GO:0035979
GeneOntologyMolecularFunction	intracellularly gated calcium channel activity	TRPM2 ITPR1 ITPR2	1.78e-04	18	124	3	GO:0015278
GeneOntologyMolecularFunction	histone H2AX kinase activity	ATR PRKDC	3.78e-04	5	124	2	GO:0141003
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	HNF1B ZNF267 ZNF429 ZNF208 STAT5A STAT5B OVOL2 ZNF675 ZNF430 ZNF708 ZNF43 ZNF728 ZNF724 ZBTB10 ZNF749 SUZ12 ZNF99 ZNF726 ZNF681 ZNF554	6.52e-04	1459	124	20	GO:0000977
GeneOntologyBiologicalProcess	transposable element silencing	TDRD9 ZNF208 ZNF43 ZNF99 ZNF726	8.15e-06	46	124	5	GO:0010526
GeneOntologyBiologicalProcess	retrotransposition	TDRD9 ZNF208 ZNF43 ZNF99 ZNF726	1.01e-05	48	124	5	GO:0032197
GeneOntologyBiologicalProcess	transposition	TDRD9 ZNF208 ZNF43 ZNF99 ZNF726	1.24e-05	50	124	5	GO:0032196
GeneOntologyBiologicalProcess	positive regulation of developmental growth	MYO5B PARP2 STAT5A STAT5B ITSN2 PLCB1 MACF1 C3 PRKDC	1.40e-05	238	124	9	GO:0048639
GeneOntologyBiologicalProcess	negative regulation of erythrocyte differentiation	STAT5A STAT5B LDB1	3.38e-05	11	124	3	GO:0045647
GeneOntologyBiologicalProcess	response to interleukin-15	STAT5A STAT5B PLCB1	4.48e-05	12	124	3	GO:0070672
GeneOntologyBiologicalProcess	development of secondary male sexual characteristics	STAT5A STAT5B	1.07e-04	3	124	2	GO:0046544
GeneOntologyBiologicalProcess	non-motile cilium assembly	IFT57 SEPTIN9 KCNF1 BBS7 PIBF1	1.08e-04	78	124	5	GO:1905515
GeneOntologyBiologicalProcess	cilium organization	CCDC146 IFT57 CEP162 SEPTIN9 CCDC88C KIFAP3 KCNF1 BBS7 RAB3IP CEP70 PIBF1	1.43e-04	476	124	11	GO:0044782
GeneOntologyCellularComponent	centrosome	FAM184A CCDC146 IFT57 CEP162 UBR4 CCDC88C KIFAP3 BBS7 CDC16 KIAA1217 RAB3IP ITSN2 CEP70 PIBF1 DCAF12	5.72e-05	770	125	15	GO:0005813
GeneOntologyCellularComponent	microtubule organizing center	FAM184A CCDC146 IFT57 CEP162 UBR4 CCDC88C KIFAP3 BBS7 CDC16 KIAA1217 RAB3IP ITSN2 CEP70 CCDC102B PIBF1 DCAF12	1.19e-04	919	125	16	GO:0005815
Domain	KRAB	ZNF267 ZNF429 ZNF208 ZNF675 ZNF430 ZNF708 ZNF43 ZNF728 ZNF749 ZNF99 ZNF726 ZNF681 ZNF554	6.98e-07	358	123	13	PS50805
Domain	KRAB	ZNF267 ZNF429 ZNF208 ZNF675 ZNF430 ZNF708 ZNF43 ZNF728 ZNF749 ZNF99 ZNF726 ZNF681 ZNF554	6.98e-07	358	123	13	PF01352
Domain	KRAB	ZNF267 ZNF429 ZNF208 ZNF675 ZNF430 ZNF708 ZNF43 ZNF728 ZNF749 ZNF99 ZNF726 ZNF681 ZNF554	9.80e-07	369	123	13	SM00349
Domain	KRAB	ZNF267 ZNF429 ZNF208 ZNF675 ZNF430 ZNF708 ZNF43 ZNF728 ZNF749 ZNF99 ZNF726 ZNF681 ZNF554	1.01e-06	370	123	13	IPR001909
Domain	ZINC_FINGER_C2H2_2	ZNF609 ZNF267 ZNF429 ZNF208 OVOL2 ZNF675 ZNF430 ZNF708 PRDM8 ZNF43 ZNF728 ZBTB10 ZNF749 SUZ12 ZNF99 ZNF726 ZNF681 ZNF554	3.20e-06	775	123	18	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF609 ZNF267 ZNF429 ZNF208 OVOL2 ZNF675 ZNF430 ZNF708 PRDM8 ZNF43 ZNF728 ZBTB10 ZNF749 SUZ12 ZNF99 ZNF726 ZNF681 ZNF554	3.32e-06	777	123	18	PS00028
Domain	Znf_C2H2-like	ZNF609 ZNF267 ZNF429 ZNF208 OVOL2 ZNF675 ZNF430 ZNF708 PRDM8 ZNF43 ZNF728 ZBTB10 ZNF749 SUZ12 ZNF99 ZNF726 ZNF681 ZNF554	4.64e-06	796	123	18	IPR015880
Domain	-	DSP DST MACF1	5.49e-06	6	123	3	3.90.1290.10
Domain	ZnF_C2H2	ZNF609 ZNF267 ZNF429 ZNF208 OVOL2 ZNF675 ZNF430 ZNF708 PRDM8 ZNF43 ZNF728 ZBTB10 ZNF749 SUZ12 ZNF99 ZNF726 ZNF681 ZNF554	5.70e-06	808	123	18	SM00355
Domain	zf-C2H2_6	ZNF267 ZNF429 ZNF208 ZNF675 ZNF43 ZNF728 ZNF749 ZNF99 ZNF726 ZNF681 ZNF554	7.37e-06	314	123	11	PF13912
Domain	Plectin	DSP DST MACF1	9.57e-06	7	123	3	PF00681
Domain	Plectin_repeat	DSP DST MACF1	9.57e-06	7	123	3	IPR001101
Domain	PLEC	DSP DST MACF1	9.57e-06	7	123	3	SM00250
Domain	-	ZNF267 ZNF429 ZNF208 OVOL2 ZNF675 ZNF430 ZNF708 PRDM8 ZNF43 ZNF728 ZBTB10 ZNF749 ZNF99 ZNF726 ZNF681 ZNF554	9.92e-06	679	123	16	3.30.160.60
Domain	zf-C2H2	ZNF267 ZNF429 ZNF208 OVOL2 ZNF675 ZNF430 ZNF708 PRDM8 ZNF43 ZNF728 ZBTB10 ZNF749 ZNF99 ZNF726 ZNF681 ZNF554	1.28e-05	693	123	16	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF267 ZNF429 ZNF208 OVOL2 ZNF675 ZNF430 ZNF708 PRDM8 ZNF43 ZNF728 ZBTB10 ZNF749 ZNF99 ZNF726 ZNF681 ZNF554	1.30e-05	694	123	16	IPR013087
Domain	ARM-type_fold	RELCH ATR UBR4 FHOD3 ITPR1 ITPR2 KIFAP3 ANKAR CLTC PRKDC XPO7	1.51e-05	339	123	11	IPR016024
Domain	Znf_C2H2	ZNF609 ZNF267 ZNF429 ZNF208 OVOL2 ZNF675 ZNF430 ZNF708 PRDM8 ZNF43 ZNF728 ZBTB10 ZNF749 ZNF99 ZNF726 ZNF681 ZNF554	2.12e-05	805	123	17	IPR007087
Domain	Spectrin_repeat	DSP SPTB DST MACF1	3.74e-05	29	123	4	IPR002017
Domain	SPEC	DSP SPTB DST MACF1	5.58e-05	32	123	4	SM00150
Domain	Spectrin/alpha-actinin	DSP SPTB DST MACF1	5.58e-05	32	123	4	IPR018159
Domain	InsP3_rcpt-bd	ITPR1 ITPR2	1.29e-04	3	123	2	IPR000493
Domain	TPR-like_helical_dom	UTP6 ATR TTC9C TTK P3H2 CDC16 CLTC PRKDC	1.56e-04	233	123	8	IPR011990
Domain	Calsequestrin	PDIA4 TMX3	2.56e-04	4	123	2	IPR001393
Domain	ARM-like	RELCH ATR FHOD3 KIFAP3 ANKAR CEP70 PRKDC XPO7	4.23e-04	270	123	8	IPR011989
Domain	FATC	ATR PRKDC	4.25e-04	5	123	2	PF02260
Domain	-	UTP6 ATR TTC9C TTK P3H2 CDC16 CLTC	4.45e-04	207	123	7	1.25.40.10
Domain	Spectrin	SPTB DST MACF1	4.48e-04	23	123	3	PF00435
Domain	ACTININ_2	SPTB DST MACF1	4.48e-04	23	123	3	PS00020
Domain	ACTININ_1	SPTB DST MACF1	4.48e-04	23	123	3	PS00019
Domain	Actinin_actin-bd_CS	SPTB DST MACF1	4.48e-04	23	123	3	IPR001589
Domain	BRK	CHD9 CHD8	6.34e-04	6	123	2	SM00592
Domain	RIH_assoc-dom	ITPR1 ITPR2	6.34e-04	6	123	2	IPR013662
Domain	GAR	DST MACF1	6.34e-04	6	123	2	PS51460
Domain	BRK_domain	CHD9 CHD8	6.34e-04	6	123	2	IPR006576
Domain	Ins145_P3_rec	ITPR1 ITPR2	6.34e-04	6	123	2	PF08709
Domain	GAS2	DST MACF1	6.34e-04	6	123	2	PF02187
Domain	RIH_assoc	ITPR1 ITPR2	6.34e-04	6	123	2	PF08454
Domain	RIH_dom	ITPR1 ITPR2	6.34e-04	6	123	2	IPR000699
Domain	Ins145_P3_rcpt	ITPR1 ITPR2	6.34e-04	6	123	2	IPR014821
Domain	Ryanodine_recept-rel	ITPR1 ITPR2	6.34e-04	6	123	2	IPR015925
Domain	FAT	ATR PRKDC	6.34e-04	6	123	2	PS51189
Domain	FATC	ATR PRKDC	6.34e-04	6	123	2	PS51190
Domain	-	ITPR1 ITPR2	6.34e-04	6	123	2	1.25.10.30
Domain	FAT	ATR PRKDC	6.34e-04	6	123	2	PF02259
Domain	PIK-rel_kinase_FAT	ATR PRKDC	6.34e-04	6	123	2	IPR003151
Domain	FATC_dom	ATR PRKDC	6.34e-04	6	123	2	IPR003152
Domain	-	DST MACF1	6.34e-04	6	123	2	3.30.920.20
Domain	RYDR_ITPR	ITPR1 ITPR2	6.34e-04	6	123	2	PF01365
Domain	PIK_FAT	ATR PRKDC	6.34e-04	6	123	2	IPR014009
Domain	BRK	CHD9 CHD8	6.34e-04	6	123	2	PF07533
Domain	GAS_dom	DST MACF1	6.34e-04	6	123	2	IPR003108
Domain	GAS2	DST MACF1	6.34e-04	6	123	2	SM00243
Domain	FATC	ATR PRKDC	6.34e-04	6	123	2	SM01343
Domain	STAT_TF_DNA-bd_sub	STAT5A STAT5B	8.84e-04	7	123	2	IPR012345
Domain	STAT	STAT5A STAT5B	8.84e-04	7	123	2	IPR001217
Domain	STAT_int	STAT5A STAT5B	8.84e-04	7	123	2	SM00964
Domain	STAT_TF_DNA-bd	STAT5A STAT5B	8.84e-04	7	123	2	IPR013801
Domain	STAT_bind	STAT5A STAT5B	8.84e-04	7	123	2	PF02864
Domain	STAT_int	STAT5A STAT5B	8.84e-04	7	123	2	PF02865
Domain	-	STAT5A STAT5B	8.84e-04	7	123	2	1.10.532.10
Domain	STAT_alpha	STAT5A STAT5B	8.84e-04	7	123	2	PF01017
Domain	-	STAT5A STAT5B	8.84e-04	7	123	2	1.20.1050.20
Domain	STAT_TF_prot_interaction	STAT5A STAT5B	8.84e-04	7	123	2	IPR013799
Domain	STAT_TF_coiled-coil	STAT5A STAT5B	8.84e-04	7	123	2	IPR015988
Domain	-	STAT5A STAT5B	8.84e-04	7	123	2	2.60.40.630
Domain	CH	SPTB DST MACF1 VAV3	8.89e-04	65	123	4	SM00033
Domain	Ion_trans_dom	TRPM2 ITPR1 ITPR2 KCNF1 TRPM8	9.46e-04	114	123	5	IPR005821
Domain	Ion_trans	TRPM2 ITPR1 ITPR2 KCNF1 TRPM8	9.46e-04	114	123	5	PF00520
Domain	STAT_TF_alpha	STAT5A STAT5B	1.17e-03	8	123	2	IPR013800
Domain	Disulphide_isomerase	PDIA4 TMX3	1.17e-03	8	123	2	IPR005788
Domain	CH	SPTB DST MACF1 VAV3	1.17e-03	70	123	4	PF00307
Domain	-	SPTB DST MACF1 VAV3	1.24e-03	71	123	4	1.10.418.10
Domain	CH	SPTB DST MACF1 VAV3	1.37e-03	73	123	4	PS50021
Domain	CH-domain	SPTB DST MACF1 VAV3	1.52e-03	75	123	4	IPR001715
Domain	-	DUOX2 STAT5A STAT5B DST ITSN2 PLCB1 MACF1	1.72e-03	261	123	7	1.10.238.10
Domain	MIR	ITPR1 ITPR2	1.87e-03	10	123	2	PF02815
Domain	MIR_motif	ITPR1 ITPR2	1.87e-03	10	123	2	IPR016093
Domain	MIR	ITPR1 ITPR2	1.87e-03	10	123	2	PS50919
Domain	MIR	ITPR1 ITPR2	1.87e-03	10	123	2	SM00472
Domain	Peptidase_S9	ABHD17C FAP	2.28e-03	11	123	2	PF00326
Domain	Peptidase_S9	ABHD17C FAP	2.28e-03	11	123	2	IPR001375
Domain	EF-hand-dom_pair	DUOX2 STAT5A STAT5B DST ITSN2 PLCB1 MACF1	2.93e-03	287	123	7	IPR011992
Domain	Thioredoxin	PDIA4 TMX3	3.20e-03	13	123	2	IPR005746
Domain	PI3/4_kinase_CS	ATR PRKDC	4.27e-03	15	123	2	IPR018936
Domain	SH2	LCP2 STAT5A STAT5B VAV3	4.47e-03	101	123	4	PF00017
Domain	TPR_REGION	TTC9C P3H2 CDC16 CEP70 PRKDC	4.74e-03	165	123	5	PS50293
Domain	TPR	TTC9C P3H2 CDC16 CEP70 PRKDC	4.74e-03	165	123	5	PS50005
Domain	-	ATR PRKDC	4.86e-03	16	123	2	1.10.1070.11
Domain	PI3Kc	ATR PRKDC	4.86e-03	16	123	2	SM00146
Domain	HEAT_type_2	RELCH ATR	5.48e-03	17	123	2	IPR021133
Domain	Thioredoxin_CS	PDIA4 TMX3	5.48e-03	17	123	2	IPR017937
Domain	SH2	LCP2 STAT5A STAT5B VAV3	6.05e-03	110	123	4	SM00252
Domain	PI3_PI4_kinase	ATR PRKDC	6.14e-03	18	123	2	PF00454
Domain	PI3_4_KINASE_1	ATR PRKDC	6.14e-03	18	123	2	PS00915
Domain	PI3_4_KINASE_2	ATR PRKDC	6.14e-03	18	123	2	PS00916
Domain	PI3/4_kinase_cat_dom	ATR PRKDC	6.14e-03	18	123	2	IPR000403
Domain	PI3_4_KINASE_3	ATR PRKDC	6.14e-03	18	123	2	PS50290
Domain	SH2	LCP2 STAT5A STAT5B VAV3	6.24e-03	111	123	4	PS50001
Domain	SH2	LCP2 STAT5A STAT5B VAV3	6.44e-03	112	123	4	IPR000980
Pathway	KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY	LCP2 ITPR1 ITPR2 VAV3	6.38e-06	19	93	4	M47733
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY	ITPR1 ITPR2 PLCB1	3.23e-05	10	93	3	M47661
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY	ITPR1 ITPR2 PLCB1	4.41e-05	11	93	3	M49033
Pathway	WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR	TRAPPC11 IFT57 CEP162 KIFAP3 BBS7 PIBF1	5.99e-05	103	93	6	M39826
Pathway	KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY	ITPR1 ITPR2 PLCB1	7.58e-05	13	93	3	M47656
Pathway	REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS	TRIP11 STAT5A STAT5B	2.49e-04	19	93	3	M41732
Pathway	KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY	ITPR1 ITPR2 PLCB1	2.92e-04	20	93	3	M47688
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY	ITPR1 ITPR2 PLCB1	3.39e-04	21	93	3	M47689
Pathway	REACTOME_CILIUM_ASSEMBLY	IFT57 CEP162 TRIP11 KIFAP3 BBS7 RAB3IP CEP70	3.63e-04	201	93	7	M27472
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY	ITPR1 ITPR2 PLCB1	3.91e-04	22	93	3	M47690
Pathway	KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY	ITPR1 ITPR2 PLCB1	3.91e-04	22	93	3	M47675
Pathway	KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPH_TO_TCR_NFAT_SIGNALING_PATHWAY	LCP2 VAV3	4.25e-04	5	93	2	M48994
Pathway	KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY	STAT5A STAT5B	4.25e-04	5	93	2	M48987
Pathway	KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY	STAT5A STAT5B	4.25e-04	5	93	2	M48986
Pathway	KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY	STAT5A STAT5B	4.25e-04	5	93	2	M49006
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY	ITPR1 ITPR2	4.25e-04	5	93	2	M49000
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY	ITPR1 ITPR2 PLCB1	4.47e-04	23	93	3	M47676
Pathway	WP_COMPLEMENT_AND_COAGULATION_CASCADES	CFH CLTC C2 C3	5.74e-04	58	93	4	M39649
Pathway	REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE	IFT57 CEP162 TRIP11 KIFAP3 BBS7 RAB3IP CEP70	5.74e-04	217	93	7	MM14708
Pathway	WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES	CFH CLTC C2 C3	6.12e-04	59	93	4	M48343
Pathway	REACTOME_INTERLEUKIN_9_SIGNALING	STAT5A STAT5B	6.35e-04	6	93	2	MM15581
Pathway	KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY	ITPR1 ITPR2	6.35e-04	6	93	2	M47960
Pathway	REACTOME_INTERLEUKIN_21_SIGNALING	STAT5A STAT5B	6.35e-04	6	93	2	MM15621
Pathway	REACTOME_CA2_PATHWAY	TNRC6C ITPR1 ITPR2 PLCB1	7.39e-04	62	93	4	M27321
Pathway	REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE	IFT57 CEP162 CHD9 TRIP11 KIFAP3 BBS7 RAB3IP CEP70	7.63e-04	297	93	8	M27050
Pathway	REACTOME_FLT3_SIGNALING_IN_DISEASE	TRIP11 STAT5A STAT5B	8.08e-04	28	93	3	M41724
Pathway	REACTOME_STAT5_ACTIVATION	STAT5A STAT5B	8.85e-04	7	93	2	M27953
Pathway	KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY	STAT5A STAT5B	8.85e-04	7	93	2	M47581
Pathway	KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY	STAT5A STAT5B	8.85e-04	7	93	2	M47646
Pathway	REACTOME_ACTIVATION_OF_C3_AND_C5	C2 C3	8.85e-04	7	93	2	MM14685
Pathway	KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY	STAT5A STAT5B	8.85e-04	7	93	2	M47430
Pathway	REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5	STAT5A STAT5B	8.85e-04	7	93	2	M27907
Pathway	REACTOME_ACTIVATION_OF_C3_AND_C5	C2 C3	1.17e-03	8	93	2	M27031
Pathway	WP_WHITE_FAT_CELL_DIFFERENTIATION	STAT5A STAT5B CTNNA1	1.20e-03	32	93	3	M39333
Pathway	REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION	TNRC6C PRDM8 CTNNA1	1.20e-03	32	93	3	M48012
Pathway	WP_WHITE_FAT_CELL_DIFFERENTIATION	STAT5A STAT5B CTNNA1	1.31e-03	33	93	3	MM15869
Pathway	KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY	ITPR1 ITPR2	1.50e-03	9	93	2	M47852
Pathway	REACTOME_INTERLEUKIN_9_SIGNALING	STAT5A STAT5B	1.50e-03	9	93	2	M27861
Pathway	BIOCARTA_IL22BP_PATHWAY	STAT5A STAT5B	1.50e-03	9	93	2	MM1419
Pathway	BIOCARTA_IL22BP_PATHWAY	STAT5A STAT5B	1.50e-03	9	93	2	M8066
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	ATR ZNF267 ZNF429 ZNF208 TNRC6C ZNF675 ZNF430 ZNF708 LDB1 ZNF43 CDC16 ZNF724 ZNF749 SUZ12 ZNF99 ZNF726 TOP3A ZNF681 ZNF554	1.56e-03	1387	93	19	M734
Pathway	REACTOME_INTERLEUKIN_21_SIGNALING	STAT5A STAT5B	1.87e-03	10	93	2	M27898
Pathway	REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS	STAT5A STAT5B	1.87e-03	10	93	2	M41731
Pathway	REACTOME_INTERLEUKIN_2_SIGNALING	STAT5A STAT5B	1.87e-03	10	93	2	MM15618
Pubmed	Expansion and diversification of KRAB zinc-finger genes within a cluster including Regulator of sex-limitation 1 and 2.	ZNF429 ZNF208 ZNF43 ZNF99 ZNF726 ZNF681	1.03e-11	15	127	6	15885501
Pubmed	Regulator of sex-limitation (Rsl) encodes a pair of KRAB zinc-finger genes that control sexually dimorphic liver gene expression.	ZNF429 ZNF208 ZNF43 ZNF99 ZNF726 ZNF681	9.33e-10	29	127	6	14563677
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF267 ZNF208 ZNF430 ZNF708 ZNF728 ZNF724 ZNF749 ZNF726 ZNF681 ZNF554	1.40e-09	181	127	10	37372979
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ZNF609 GOLM2 SEPTIN9 CARMIL1 SPTB TRPM2 CHD9 TNRC6C TECTA STAT5B CNNM4 ZNF708 ATAD3B LDB1 KIAA1217 ANKAR RAB3IP MACF1 RASSF3 TMX3 DOP1A XPO7	2.24e-08	1489	127	22	28611215
Pubmed	Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR.	ZNF429 ZNF208 ZNF43 ZNF99 ZNF726 ZNF681	2.59e-08	49	127	6	9630514
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYO5B DSP MYH7B PCLO UBR4 DUOX2 PTPN21 PDIA4 ZNF675 PRDM8 ATAD3B DST WDR75 KRT40 ITSN2 CLTC MACF1 GPR171 PRKDC TNNT1 DOP1A	6.24e-08	1442	127	21	35575683
Pubmed	EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions.	SEPTIN9 DST KIAA1217 CLTC CTNNA1 PRKDC	1.21e-07	63	127	6	29162697
Pubmed	Association between polymorphisms of complement pathway genes and age-related macular degeneration in a Chinese population.	CFH C2 C3	1.90e-07	4	127	3	23233260
Pubmed	Association Between Complement Factor C2/C3/CFB/CFH Polymorphisms and Age-Related Macular Degeneration: A Meta-Analysis.	CFH C2 C3	1.90e-07	4	127	3	30179527
Pubmed	[Polymorphisms of complement factor genes and age-related macular degeneration in a German population].	CFH C2 C3	1.90e-07	4	127	3	19399715
Pubmed	Twins with different personalities: STAT5B-but not STAT5A-has a key role in BCR/ABL-induced leukemia.	STAT5A STAT5B PRKDC	1.90e-07	4	127	3	30679796
Pubmed	Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components.	CFH C2 C3	1.90e-07	4	127	3	24983375
Pubmed	A human MAP kinase interactome.	DSP CHD8 LCP2 DST ITSN2 CLTC PLCB1 MACF1 VAV3 CTNNA1 PRKDC PIBF1	2.44e-07	486	127	12	20936779
Pubmed	Complement component 3: an assessment of association with AMD and analysis of gene-gene and gene-environment interactions in a Northern Irish cohort.	CFH C2 C3	4.73e-07	5	127	3	20157618
Pubmed	STAT5-regulated microRNA-193b controls haematopoietic stem and progenitor cell expansion by modulating cytokine receptor signalling.	STAT5A STAT5B PRKDC	4.73e-07	5	127	3	26603207
Pubmed	Peripheral retinal drusen and reticular pigment: association with CFHY402H and CFHrs1410996 genotypes in family and twin studies.	CFH C2 C3	4.73e-07	5	127	3	18936151
Pubmed	CFH haplotypes and ARMS2, C2, C3, and CFB alleles show association with susceptibility to age-related macular degeneration in Mexicans.	CFH C2 C3	4.73e-07	5	127	3	24453474
Pubmed	Association study of complement factor H, C2, CFB, and C3 and age-related macular degeneration in a Han Chinese population.	CFH C2 C3	4.73e-07	5	127	3	20523265
Pubmed	Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables.	CFH C2 C3	9.43e-07	6	127	3	19117936
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	RELCH ZNF609 MYO5B DSP IFT57 CEP162 GOLM2 PTPN21 ITPR1 ITPR2 PDIA4 CNNM4 KLHL15 CLTC CTNNA1 PIBF1	1.49e-06	1049	127	16	27880917
Pubmed	The KRAB zinc finger protein RSL1 regulates sex- and tissue-specific promoter methylation and dynamic hormone-responsive chromatin configuration.	ZNF429 STAT5B ZNF726	1.65e-06	7	127	3	22801370
Pubmed	Multilocus analysis of age-related macular degeneration.	CFH C2 C3	1.65e-06	7	127	3	19259132
Pubmed	Progression of geographic atrophy and genotype in age-related macular degeneration.	CFH C2 C3	1.65e-06	7	127	3	20381870
Pubmed	Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration.	CFH C2 C3	2.63e-06	8	127	3	20888482
Pubmed	Comparative analysis of KRAB zinc finger proteins in rodents and man: evidence for several evolutionarily distinct subfamilies of KRAB zinc finger genes.	ZNF429 ZNF726 ZNF681	3.93e-06	9	127	3	10360839
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	UTP6 TRAPPC11 UBR4 KIF16B LRRC70 TRIP11 ATAD3B WDR75 BBS7 ITSN2 PLCB1 CCDC102B	4.14e-06	638	127	12	31182584
Pubmed	Tagging genes with cassette-exchange sites.	RELCH SEPTIN9 UBR4 ZNF429 CHD8 MACF1 ZNF726 ZNF681 SNX5	4.20e-06	335	127	9	15741177
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CFH DSP SPTB UBR4 CHD9 TRIP11 TMED4 STAT5B HSPA13 DST LDB1 CLTC CEP70 MACF1 CTNNA1 PRKDC SNX5	4.63e-06	1285	127	17	35914814
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	UTP6 DSP UBR4 CHD8 PDIA4 DST WDR75 CLTC MACF1 CTNNA1 PRKDC XPO7	5.24e-06	653	127	12	22586326
Pubmed	Functional analysis of the SRY-KRAB interaction in mouse sex determination.	ZNF208 ZNF43 ZNF99	5.60e-06	10	127	3	18588511
Pubmed	Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes.	CFH C2 C3	5.60e-06	10	127	3	22705344
Pubmed	Sry associates with the heterochromatin protein 1 complex by interacting with a KRAB domain protein.	ZNF208 ZNF43 ZNF99	7.68e-06	11	127	3	15469996
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	FAM184A UBR4 KIF16B TTK ITPR1 ITPR2 HSPA13 PDIA4 ATAD3B WDR75 BBS7 CLTC MACF1 CTNNA1 TMX3 PIBF1 USP48 SNX5	8.04e-06	1487	127	18	33957083
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	CFH COL12A1 ATR GOLM2 TMED4 ITPR1 ITPR2 HSPA13 PDIA4 FAP P3H2 CTNNA1 TMX3 USP48 SNX5 DCAF12	8.29e-06	1201	127	16	35696571
Pubmed	Mechanisms and Consequences of Dopamine Depletion-Induced Attenuation of the Spinophilin/Neurofilament Medium Interaction.	RELCH DSP PCLO ATAD3B KIAA1217 CLTC	9.06e-06	131	127	6	28634551
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	ATR DSP SEPTIN9 CARD10 CHD8 TTK CDC16 MACF1 CTNNA1 PRKDC USP48	1.01e-05	582	127	11	20467437
Pubmed	Definitive evidence using enucleated cytoplasts for a nongenomic basis for the cystic change in endoplasmic reticulum structure caused by STAT5a/b siRNAs.	STAT5A STAT5B	1.32e-05	2	127	2	23151802
Pubmed	Signal transducer and activator of transcription 5 (STAT5) paralog dose governs T cell effector and regulatory functions.	STAT5A STAT5B	1.32e-05	2	127	2	26999798
Pubmed	Human serum complement C3 and factor H in the syndrome of hemolysis, elevated liver enzymes, and low platelet count.	CFH C3	1.32e-05	2	127	2	19703145
Pubmed	Membrane localization and function of Vav3 in T cells depend on its association with the adapter SLP-76.	LCP2 VAV3	1.32e-05	2	127	2	15708849
Pubmed	A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions.	STAT5A STAT5B	1.32e-05	2	127	2	31443474
Pubmed	Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.	STAT5A STAT5B	1.32e-05	2	127	2	12377952
Pubmed	Type XII collagen contributes to diversities in human corneal and limbal extracellular matrices.	COL12A1 C3	1.32e-05	2	127	2	9344363
Pubmed	Importance of a conserved sequence motif in transmembrane segment S3 for the gating of human TRPM8 and TRPM2.	TRPM2 TRPM8	1.32e-05	2	127	2	23185472
Pubmed	The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity.	CFH C3	1.32e-05	2	127	2	19549636
Pubmed	A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development.	STAT5A STAT5B	1.32e-05	2	127	2	21127177
Pubmed	The gammac-cytokine regulated transcription factor, STAT5, increases HIV-1 production in primary CD4 T cells.	STAT5A STAT5B	1.32e-05	2	127	2	16289657
Pubmed	Inhibition of Stat5a/b Enhances Proteasomal Degradation of Androgen Receptor Liganded by Antiandrogens in Prostate Cancer.	STAT5A STAT5B	1.32e-05	2	127	2	25552366
Pubmed	Deletion of STAT5a/b in vascular smooth muscle abrogates the male bias in hypoxic pulmonary hypertension in mice: implications in the human disease.	STAT5A STAT5B	1.32e-05	2	127	2	25470773
Pubmed	Acf7 (MACF) is an actin and microtubule linker protein whose expression predominates in neural, muscle, and lung development.	DST MACF1	1.32e-05	2	127	2	11002341
Pubmed	Constitutively active Stat5A and Stat5B promote adipogenesis.	STAT5A STAT5B	1.32e-05	2	127	2	21431790
Pubmed	Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II).	CFH C3	1.32e-05	2	127	2	16612335
Pubmed	Stat5 Is Required for CD103+ Dendritic Cell and Alveolar Macrophage Development and Protection from Lung Injury.	STAT5A STAT5B	1.32e-05	2	127	2	28500076
Pubmed	STAT5 isoforms regulate colorectal cancer cell apoptosis via reduction of mitochondrial membrane potential and generation of reactive oxygen species.	STAT5A STAT5B	1.32e-05	2	127	2	21826656
Pubmed	DNA structure-specific priming of ATR activation by DNA-PKcs.	ATR PRKDC	1.32e-05	2	127	2	23897887
Pubmed	The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b.	CFH C3	1.32e-05	2	127	2	19112495
Pubmed	Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs.	STAT5A STAT5B	1.32e-05	2	127	2	7720707
Pubmed	Ins(1,4,5)P(3) regulates phospholipase Cbeta1 expression in cardiomyocytes.	ITPR2 PLCB1	1.32e-05	2	127	2	18692062
Pubmed	STAT5A and STAT5B have opposite correlations with drug response gene expression.	STAT5A STAT5B	1.32e-05	2	127	2	27264955
Pubmed	Nongenomic STAT5-dependent effects on Golgi apparatus and endoplasmic reticulum structure and function.	STAT5A STAT5B	1.32e-05	2	127	2	22159083
Pubmed	Immunolocalization of type 2 inositol 1,4,5-trisphosphate receptors in cardiac myocytes from newborn mice.	ITPR1 ITPR2	1.32e-05	2	127	2	15201137
Pubmed	Noncoding variant in the complement factor H gene and risk of exudative age-related macular degeneration in a Chinese population.	CFH C3	1.32e-05	2	127	2	19850835
Pubmed	STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease.	STAT5A STAT5B	1.32e-05	2	127	2	20008792
Pubmed	STAT5 Regulation of Sex-Dependent Hepatic CpG Methylation at Distal Regulatory Elements Mapping to Sex-Biased Genes.	STAT5A STAT5B	1.32e-05	2	127	2	33199496
Pubmed	Contribution of the S5-pore-S6 domain to the gating characteristics of the cation channels TRPM2 and TRPM8.	TRPM2 TRPM8	1.32e-05	2	127	2	20587417
Pubmed	Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2.	ITPR1 ITPR2	1.32e-05	2	127	2	23582047
Pubmed	The influence of STAT5 antisense oligodeoxynucleotides on the proliferation and apoptosis of selected human cutaneous T-cell lymphoma cell lines.	STAT5A STAT5B	1.32e-05	2	127	2	16502315
Pubmed	Stat5: an essential regulator of mast cell biology.	STAT5A STAT5B	1.32e-05	2	127	2	12217382
Pubmed	Brain STAT5 Modulates Long-Term Metabolic and Epigenetic Changes Induced by Pregnancy and Lactation in Female Mice.	STAT5A STAT5B	1.32e-05	2	127	2	31599926
Pubmed	DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites.	STAT5A STAT5B	1.32e-05	2	127	2	10594041
Pubmed	Mitochondrial translocation of signal transducer and activator of transcription 5 (STAT5) in leukemic T cells and cytokine-stimulated cells.	STAT5A STAT5B	1.32e-05	2	127	2	21036145
Pubmed	Stimulation of lipolysis but not of leptin release by growth hormone is abolished in adipose tissue from Stat5a and b knockout mice.	STAT5A STAT5B	1.32e-05	2	127	2	10486277
Pubmed	Identification of human STAT5-dependent gene regulatory elements based on interspecies homology.	STAT5A STAT5B	1.32e-05	2	127	2	16840779
Pubmed	The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells.	STAT5A STAT5B	1.32e-05	2	127	2	15128421
Pubmed	STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice.	STAT5A STAT5B	1.32e-05	2	127	2	30377054
Pubmed	Gain-of-function of Stat5 leads to excessive granulopoiesis and lethal extravasation of granulocytes to the lung.	STAT5A STAT5B	1.32e-05	2	127	2	23565285
Pubmed	Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer.	STAT5A STAT5B	1.32e-05	2	127	2	32790723
Pubmed	In vivo identification of novel STAT5 target genes.	STAT5A STAT5B	1.32e-05	2	127	2	18492722
Pubmed	Distinctive roles of STAT5a and STAT5b in sexual dimorphism of hepatic P450 gene expression. Impact of STAT5a gene disruption.	STAT5A STAT5B	1.32e-05	2	127	2	10066807
Pubmed	Molecular characterization of STAT5A- and STAT5B-encoding genes reveals extended intragenic sequence homogeneity in cattle and mouse and different degrees of divergent evolution of various domains.	STAT5A STAT5B	1.32e-05	2	127	2	10835485
Pubmed	Loss of Adipocyte STAT5 Confers Increased Depot-Specific Adiposity in Male and Female Mice That Is Not Associated With Altered Adipose Tissue Lipolysis.	STAT5A STAT5B	1.32e-05	2	127	2	35464049
Pubmed	Loss of cytokine-STAT5 signaling in the CNS and pituitary gland alters energy balance and leads to obesity.	STAT5A STAT5B	1.32e-05	2	127	2	18286195
Pubmed	Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells.	STAT5A STAT5B	1.32e-05	2	127	2	23773921
Pubmed	Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells.	STAT5A STAT5B	1.32e-05	2	127	2	8631883
Pubmed	Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2.	STAT5A STAT5B	1.32e-05	2	127	2	11030348
Pubmed	Association between STAT5 polymorphisms and glioblastoma risk in Han Chinese population.	STAT5A STAT5B	1.32e-05	2	127	2	24878107
Pubmed	Factor H binding proteins protect division septa on encapsulated Streptococcus pneumoniae against complement C3b deposition and amplification.	CFH C3	1.32e-05	2	127	2	30139996
Pubmed	Regulation of eosinophil apoptosis by nitric oxide: Role of c-Jun-N-terminal kinase and signal transducer and activator of transcription 5.	STAT5A STAT5B	1.32e-05	2	127	2	12847485
Pubmed	An insulator element located at the cyclin B1 interacting protein 1 gene locus is highly conserved among mammalian species.	PARP2 CCNB1IP1	1.32e-05	2	127	2	26110280
Pubmed	Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma.	STAT5A STAT5B	1.32e-05	2	127	2	12835478
Pubmed	Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue.	STAT5A STAT5B	1.32e-05	2	127	2	7568026
Pubmed	Identification of STAT5A and STAT5B target genes in human T cells.	STAT5A STAT5B	1.32e-05	2	127	2	24497979
Pubmed	Polymorphisms in complement component 3 (C3F) and complement factor H (Y402H) increase the risk of postoperative neurocognitive dysfunction following carotid endarterectomy.	CFH C3	1.32e-05	2	127	2	20841369
Pubmed	Role of STAT5a in regulation of sex-specific gene expression in female but not male mouse liver revealed by microarray analysis.	STAT5A STAT5B	1.32e-05	2	127	2	17536022
Pubmed	STAT5 transcriptional activity is impaired by LIF in a mammary epithelial cell line.	STAT5A STAT5B	1.32e-05	2	127	2	17382296
Pubmed	STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation.	STAT5A STAT5B	1.32e-05	2	127	2	17911616
Pubmed	STAT5 signaling in sexually dimorphic gene expression and growth patterns.	STAT5A STAT5B	1.32e-05	2	127	2	10486314
Pubmed	The transcription factors Stat5a/b are not required for islet development but modulate pancreatic beta-cell physiology upon aging.	STAT5A STAT5B	1.32e-05	2	127	2	17599554
Pubmed	MiR-21 is under control of STAT5 but is dispensable for mammary development and lactation.	STAT5A STAT5B	1.32e-05	2	127	2	24497923
Pubmed	The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.	CFH C3	1.32e-05	2	127	2	19454698
Interaction	PDGFRB interactions	ATR UBR4 TRIP11 STAT5A STAT5B PDIA4 ATAD3B DST CLTC VAV3 PRKDC	1.68e-07	228	124	11	int:PDGFRB
Interaction	NINL interactions	FAM184A CCDC146 DSP CEP162 TNRC6C TTK CCDC88C ATAD3B KIAA1217 ITSN2 CLTC PRKDC PIBF1 TNNT1	8.96e-07	458	124	14	int:NINL
Interaction	KRT8 interactions	TRAPPC11 DSP IFT57 CEP162 UBR4 KIF16B TNRC6C LCP2 TRIP11 ZNF708 KRT40 PAN2 PIBF1	3.35e-06	441	124	13	int:KRT8
Interaction	TNRC6A interactions	FAM184A TNRC6C TRIP11 CDC16 KLHL15 ITSN2 CLTC ZBTB10 PAN2 SUZ12	9.26e-06	280	124	10	int:TNRC6A
Interaction	ZNF366 interactions	CARD10 KLHL15 CEP70	1.24e-05	8	124	3	int:ZNF366
Interaction	PCNT interactions	FAM184A CEP162 SEPTIN9 TRIP11 DST KRT40 MACF1 SUZ12 PIBF1	1.85e-05	241	124	9	int:PCNT
Interaction	NR3C1 interactions	UTP6 TRAPPC11 DSP UBR4 KIF16B CHD9 LRRC70 TRIP11 STAT5A STAT5B ATAD3B WDR75 BBS7 ITSN2 PLCB1 C3 PRKDC CCDC102B	2.86e-05	974	124	18	int:NR3C1
Interaction	ANKRD36B interactions	CHD9 CHD8 TTK ZNF708 ZNF724	3.39e-05	60	124	5	int:ANKRD36B
Interaction	ZNF329 interactions	CARD10 KRT40 CEP70 USP48	4.30e-05	32	124	4	int:ZNF329
Interaction	ZFHX3 interactions	HNF1B LDB1 KRT40 CEP70 PIBF1 DCAF12	5.80e-05	109	124	6	int:ZFHX3
Interaction	TYRO3 interactions	COL12A1 PDIA4 CNNM4 ATAD3B KRT40 CTNNA1 PRKDC	6.03e-05	160	124	7	int:TYRO3
Interaction	TNRC6B interactions	FAM184A DSP TNRC6C TRIP11 KLHL15 ITSN2 CLTC PAN2 PIBF1	6.31e-05	282	124	9	int:TNRC6B
Interaction	BRCA1 interactions	FAM184A ATR DSP SEPTIN9 UBR4 CHD9 TNRC6C TRIP11 STAT5A ITPR1 PDIA4 DST CDC16 RAB3IP CLTC CTNNA1 PRKDC SUZ12 USP48 TOP3A	7.47e-05	1249	124	20	int:BRCA1
Interaction	CEACAM16 interactions	RELCH DST SNX5	7.88e-05	14	124	3	int:CEACAM16
Interaction	MOB3C interactions	RELCH DSP SEPTIN9 UBR4 PTPN21 KRT40 CLTC ZBTB10 CTNNA1 PRKDC	8.60e-05	364	124	10	int:MOB3C
Interaction	FGFR2 interactions	UBR4 TRIP11 STAT5A STAT5B ATAD3B DST ITSN2 PRKDC	1.18e-04	239	124	8	int:FGFR2
Interaction	ZNF250 interactions	CARD10 KRT40 CEP70 CCDC102B PIBF1 TNNT1	1.30e-04	126	124	6	int:ZNF250
Interaction	LCK interactions	DSP CARMIL1 KIF16B TTC9C LCP2 TRIP11 STAT5A DST KIAA1217 MACF1 CTNNA1	1.37e-04	463	124	11	int:LCK
Cytoband	Ensembl 112 genes in cytogenetic band chr19p12	ZNF429 ZNF208 ZNF675 ZNF430 ZNF708 ZNF43 ZNF728 ZNF724 ZNF99 ZNF726 ZNF681	5.05e-14	122	127	11	chr19p12
Cytoband	19p12	ZNF208 ZNF675 ZNF430 ZNF708 ZNF728 ZNF724 ZNF99 ZNF726 ZNF681	4.16e-12	90	127	9	19p12
Cytoband	17q11.2	UTP6 TLCD1 STAT5A STAT5B SUZ12	1.45e-05	110	127	5	17q11.2
Cytoband	Ensembl 112 genes in cytogenetic band chr6q14	COL12A1 CEP162 TTK DOP1A	1.59e-04	97	127	4	chr6q14
Cytoband	2q32.2	WDR75 ANKAR	7.79e-04	15	127	2	2q32.2
Cytoband	18q21.31	ST8SIA3 ALPK2	8.88e-04	16	127	2	18q21.31
Cytoband	4q21	NPFFR2 PRDM8	1.40e-03	20	127	2	4q21
Cytoband	15q15.3	GOLM2 DUOX2	2.18e-03	25	127	2	15q15.3
Cytoband	Ensembl 112 genes in cytogenetic band chr18q21	RELCH MYO5B ST8SIA3 ALPK2	2.60e-03	205	127	4	chr18q21
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF609 ZNF267 ZNF429 ZNF208 OVOL2 ZNF675 ZNF430 ZNF708 ZNF43 ZNF728 ZBTB10 ZNF749 SUZ12 ZNF99 ZNF726 ZNF681 ZNF554	1.09e-07	718	92	17	28
GeneFamily	EF-hand domain containing\|Plakins	DSP DST MACF1	7.01e-06	8	92	3	939
GeneFamily	Inositol 1,4,5-triphosphate receptors\|Protein phosphatase 1 regulatory subunits	ITPR1 ITPR2	7.66e-05	3	92	2	297
GeneFamily	Transient receptor potential cation channels	TRPM2 PKD2L2 TRPM8	3.81e-04	28	92	3	249
GeneFamily	Complement system\|Sushi domain containing	CFH C2 C3	8.06e-04	36	92	3	492
GeneFamily	SH2 domain containing	LCP2 STAT5A STAT5B VAV3	1.76e-03	101	92	4	741
Coexpression	GALE_APL_WITH_FLT3_MUTATED_UP	CFH ATR CHD9 TTK CDC16 GIMAP6	4.00e-07	59	126	6	M3845
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	ATR KIF16B TTK TRIP11 ITPR1 ITPR2 ZNF430 FAP ZNF43 ITSN2 CEP70 SUZ12 PIBF1 USP48	3.45e-06	656	126	14	M18979
Coexpression	ERBB2_UP.V1_DN	ATR IFT57 ZNF267 TTK HSPA13 ZNF430 ZNF43 ZBTB10	5.20e-06	197	126	8	M2635
Coexpression	COATES_MACROPHAGE_M1_VS_M2_UP	CFH ZNF208 DST ZNF43 ZNF99 ZNF681	1.01e-05	102	126	6	MM749
Coexpression	GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_UP	CFH LCP2 FBXL5 DST GPR75 CLTC SNX5	1.96e-05	171	126	7	M6746
Coexpression	HE_LIM_SUN_FETAL_LUNG_C2_DC1_CELL	CCDC146 BEND5 IFT57 KIF16B DST P3H2 RAB3IP VAV3 DOP1A	3.08e-05	328	126	9	M45723
Coexpression	DURAND_STROMA_NS_UP	ZNF208 ITPR1 ZNF43 KIAA1217 PLCB1 ZNF99 ZNF681	4.39e-05	194	126	7	MM962
Coexpression	GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN	TRAPPC11 PARP2 MAST2 CDC16 ZNF749 CCNB1IP1 TOP3A	4.68e-05	196	126	7	M4973
Coexpression	GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_DN	DSP TMED4 ITPR1 RAB3IP PLCB1 C3 RASSF3	5.15e-05	199	126	7	M7479
Coexpression	GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_UP	LCP2 TMED4 KIFAP3 PLCB1 C3 RASSF3 TMX3	5.32e-05	200	126	7	M7475
Coexpression	BROWNE_HCMV_INFECTION_30MIN_DN	DSP PTPN21 DST KCNF1 ITSN2 ZNF749	7.38e-05	145	126	6	M0
Coexpression	DE_YY1_TARGETS_DN	IFT57 TTK DST MACF1 RASSF3	8.78e-05	93	126	5	M3278
Coexpression	CUI_TCF21_TARGETS_2_DN	COL12A1 DSP ZNF208 CARD10 TRIP11 DST ZNF43 P3H2 ITSN2 MACF1 CCNB1IP1 ZNF99 ZNF726 GIMAP6	9.72e-05	888	126	14	MM1018
Coexpression	LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_DN	CFH C2 C3	9.93e-05	19	126	3	M40932
CoexpressionAtlas	kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#3_top-relative-expression-ranked_200	CFH COL12A1 C3	1.09e-05	8	125	3	gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k3_200
CoexpressionAtlas	kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#3_top-relative-expression-ranked_500	CFH COL12A1 P3H2 C3	2.10e-05	28	125	4	gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k3_500
CoexpressionAtlas	kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_1000	HNF1B MYO5B DSP CARMIL1 FHOD3 RAB3IP PLCB1	2.78e-05	148	125	7	gudmap_kidney_P4_CapMesRenVes_Crym_k3_1000
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	MAST2 ITPR2 HSPA13 ZNF708 KLHL15 CLTC MACF1 PRKDC	6.46e-08	186	127	8	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYP2B6 MYO5B DSP DUOX2 KIAA1217 CLTC C3 CTNNA1	1.01e-07	197	127	8	5c4cee914baf7cb43e9cb99cc9e3ae823856dc15
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	MAST2 HSPA13 ZNF708 KLHL15 CLTC MACF1 PRKDC	1.05e-06	185	127	7	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	(7)_Epithelial-E_(AT2)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	FAM184A CYP2B6 IFT57 MYH7B P3H2 CEP70 C3	1.29e-06	191	127	7	0fc8d109d5c50957ceef5b8b8b818b0c598b1bbe
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	CFH COL12A1 CARMIL1 CHD9 ZNF708 PLCB1 C3	1.39e-06	193	127	7	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	CFH COL12A1 CARMIL1 CHD9 ZNF708 PLCB1 C3	1.44e-06	194	127	7	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE HNF1B MYO5B PCLO FHOD3 RAB3IP VAV3	1.44e-06	194	127	7	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	CFH COL12A1 CARMIL1 CHD9 ZNF708 PLCB1 C3	1.49e-06	195	127	7	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	mild-B_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DSP BEND5 IFT57 ITPR1 FAM177B ZBTB10 VAV3	1.76e-06	200	127	7	222789b897e2a683bbfd1d00b6fd8705015d90df
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DSP IFT57 CARMIL1 ITPR1 FAM177B ZBTB10	1.01e-05	172	127	6	62ed3b70fa1f6c84ea80ff00f60d2562be292e9d
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH CHD9 TRIP11 MACF1 VAV3 PIBF1	1.15e-05	176	127	6	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122\|Adult / Lineage, Cell type, age group and donor	FAM184A CYP2B6 IFT57 ABHD17C KIAA1217 CEP70	1.15e-05	176	127	6	3fee8a367bb9755aca1b7fcc968b08e51b6e9436
ToppCell	droplet-Marrow-nan-3m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CARMIL1 CHD9 ITPR1 PDIA4 GPR171 SNX5	1.27e-05	179	127	6	dcaf2191134a586d50ebaf67dcf5b815b54a722b
ToppCell	COVID-19-kidney-Epi_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	CFH COL12A1 FHOD3 DST C3 ALPK2	1.27e-05	179	127	6	e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CARMIL1 CHD9 ITPR1 PDIA4 GPR171 SNX5	1.27e-05	179	127	6	87a69f9f83b8f0c028a4874acb238f2e079bf51f
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD9 TRIP11 ITPR2 ITSN2 MACF1 GPR171	1.39e-05	182	127	6	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	Basal\|World / shred by cell class for mouse tongue	SEPTIN9 CARD10 DST P3H2 HS6ST1 KIAA1217	1.43e-05	183	127	6	c6729a207526ff4aa48176207b9353176f631fea
ToppCell	(4)_B_cells-(4)_B_mantle\|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	DSP CARMIL1 ITPR1 FAM177B ANKAR VAV3	1.43e-05	183	127	6	21b7fb6482eb1d5d31a4029e47e0992e8ddc8e2c
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D175\|Adult / Lineage, Cell type, age group and donor	COL12A1 MYO5B IFT57 CARMIL1 PTPN21 DST	1.53e-05	185	127	6	32b4e68e551d435a732f253f6ad83408c759a642
ToppCell	Control-Epithelial_alveolar\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B DSP CARMIL1 OVOL2 P3H2 C3	1.53e-05	185	127	6	3937e026add96a396122139daf8011cfbc60e75c
ToppCell	Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|World / Lineage, Cell type, age group and donor	FAM184A CYP2B6 ABHD17C OVOL2 KIAA1217 CEP70	1.62e-05	187	127	6	81cc8435b2704a9a8287b3f54acaae0f11dd4ac7
ToppCell	COVID-19-kidney\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TRHDE HNF1B MYO5B PCLO FHOD3 P3H2	1.62e-05	187	127	6	d23aae9419d460b78b1d4092d7acd9108a47cfbe
ToppCell	facs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO5B DSP MYH7B SPTB FHOD3 ALPK2	1.67e-05	188	127	6	4db566f3f708e66730aa9e16f4d73d91dc534177
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	FAM184A MYO5B IFT57 P3H2 KIAA1217 CEP70	1.67e-05	188	127	6	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	facs-Heart-Unknown-3m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO5B DSP MYH7B SPTB FHOD3 ALPK2	1.67e-05	188	127	6	6704b92991ad8c0a910e9f36cd33d00bd26dcb8f
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	TRHDE CFH CARMIL1 CHD9 PLCB1 C3	1.83e-05	191	127	6	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYO5B DSP CARD10 PTPN21 OVOL2 KIAA1217	1.88e-05	192	127	6	8899d81306770adda893b5e146df1253971754c5
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYO5B DSP CARD10 PTPN21 OVOL2 KIAA1217	1.88e-05	192	127	6	5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH CHD9 PDIA4 DST CLTC MACF1	1.94e-05	193	127	6	06b65110db974f4ef90d3511ff34428976a52c9c
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH CHD9 PDIA4 DST CLTC MACF1	1.94e-05	193	127	6	9c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCell	facs-Brain_Myeloid-Hippocampus-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH CHD9 PDIA4 DST CLTC MACF1	1.94e-05	193	127	6	a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE HNF1B MYO5B PCLO FHOD3 P3H2	1.94e-05	193	127	6	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	BEND5 SEPTIN9 ABHD17C KCNF1 TRPM8 CCNB1IP1	1.94e-05	193	127	6	efa91167dc7a59bf32addf90ffb7bf070b2a0151
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH CHD9 PDIA4 DST CLTC MACF1	1.94e-05	193	127	6	b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW10-Myeloid\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	TRPM2 LCP2 STAT5A P3H2 C3 GIMAP6	1.99e-05	194	127	6	4f28841c7f37884fc34c6689cd6976c6559d23f1
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DSP BEND5 IFT57 ITPR1 FAM177B ZBTB10	1.99e-05	194	127	6	82753b90ca3b563275c41b6040ebbcd99b185e24
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE HNF1B MYO5B PCLO FHOD3 P3H2	1.99e-05	194	127	6	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW10-Myeloid-Microglia\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	TRPM2 LCP2 STAT5A P3H2 C3 GIMAP6	1.99e-05	194	127	6	459e836bcdb6742333684ac23d960efa5e99702f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE HNF1B MYO5B PCLO FHOD3 VAV3	2.05e-05	195	127	6	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE HNF1B MYO5B PCLO FHOD3 VAV3	2.11e-05	196	127	6	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE HNF1B PCLO FHOD3 P3H2 VAV3	2.11e-05	196	127	6	eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO5B DSP P3H2 C3 PIBF1 TNNT1	2.24e-05	198	127	6	50852713c017217c79777c95857097103bcf2fbe
ToppCell	T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	TNRC6C LCP2 CCDC88C MACF1 GPR171 GIMAP6	2.24e-05	198	127	6	1ca6cd8e75891fdfaddbb4a7342eec9ca4d11e5d
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYO5B DSP PDIA4 P3H2 C3 PIBF1	2.24e-05	198	127	6	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	LPS_anti-TNF-Epithelial_alveolar\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO5B DSP PDIA4 P3H2 C3 PIBF1	2.24e-05	198	127	6	53e9ed1b19cb26be58da0f37057caca0cdfaabeb
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO5B DSP P3H2 C3 PIBF1 TNNT1	2.24e-05	198	127	6	f006d68e6c51923be7772eea118546a5762e8a5e
ToppCell	LPS_only-Epithelial_alveolar\|LPS_only / Treatment groups by lineage, cell group, cell type	MYO5B DSP PDIA4 P3H2 C3 PIBF1	2.24e-05	198	127	6	655df75b9692d815c7f6910275e1f684ac63bf62
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYO5B DSP PDIA4 C3 PIBF1 TNNT1	2.30e-05	199	127	6	180b3997174fd63bdf3b828063a13483eb4cab29
ToppCell	LPS_IL1RA-Epithelial_alveolar\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYO5B DSP PDIA4 P3H2 C3 PIBF1	2.30e-05	199	127	6	5b140ac88ebc25ce397ae577e48f3e271faf46e7
ToppCell	ASK452-Epithelial\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	CFH CCDC146 DSP IFT57 DST C3	2.30e-05	199	127	6	e8778d4d2bc7e15b4c7989a93e5808a76738df46
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYO5B DSP PDIA4 P3H2 C3 PIBF1	2.30e-05	199	127	6	bb2e839197b9a44b632c1bb716e48d885a1c8713
ToppCell	LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	MYO5B DSP PDIA4 P3H2 C3 PIBF1	2.30e-05	199	127	6	0447f8f53389fe7c6ddc04a97d86e74122ea16f4
ToppCell	NS-control-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFH CYP2B6 CARMIL1 CHD9 KIAA1217 C3	2.30e-05	199	127	6	32bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCell	Lung_Parenchyma-Severe-Mesenchymal\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CFH COL12A1 FAP DST C3 CCDC102B	2.37e-05	200	127	6	6ce8e2cf689523993d909a27daec3d6a5824d13c
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CFH COL12A1 FAP DST C3 CCDC102B	2.37e-05	200	127	6	907427e85cebe5a18c8a310e2ffa0e180ea3cb77
ToppCell	severe-B_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DSP BEND5 IFT57 ITPR1 FAM177B ZBTB10	2.37e-05	200	127	6	0e86f52b6e146d9bbc728d8fb176fc2b53696558
ToppCell	severe-B_naive\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DSP BEND5 IFT57 ITPR1 FAM177B ZBTB10	2.37e-05	200	127	6	306df1f498ac2188eaf9f2a8d002bb73bdb9642d
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFH DSP PCLO DST KIAA1217 CTNNA1	2.37e-05	200	127	6	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	Parenchyma_COVID-19-Stromal-TX\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	CFH COL12A1 FAP DST C3 CCDC102B	2.37e-05	200	127	6	8472baa74c48b67c5f08223025885c833458290b
ToppCell	mild-B_naive\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DSP BEND5 IFT57 ITPR1 FAM177B ZBTB10	2.37e-05	200	127	6	d0467cab6a42bf780aa49046bf3231ca161dc144
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-8\|TCGA-Bladder / Sample_Type by Project: Shred V9	ZNF675 ZNF708 ZNF43 ZNF726 ZNF681	7.06e-05	150	127	5	1aa9320d97ff10994ea024751790524fe133aba9
ToppCell	Healthy/Control-RBC\|World / Disease group and Cell class	KIF16B C3 ZNF749 DOP1A DCAF12	9.58e-05	160	127	5	f10871238e7bdf3e1f65a17070000477196e50fe
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRHDE MYH7B CARMIL1 PCLO ITPR2	9.86e-05	161	127	5	f5df8c6a340d5026726804b103e32137f363ca40
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CYP2B6 MYO5B ZNF728 KIAA1217 CEP70	1.02e-04	162	127	5	5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CFH ITPR2 NPFFR2 KIAA1217 KRT40	1.11e-04	165	127	5	fee7f2f8d0e25c0d067adc73f8913721bd709a3e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BEND5 ITPR1 FAM177B ZNF681 DOP1A	1.11e-04	165	127	5	83095377aedf960c05baa523869bdbd2b0a05f2d
ToppCell	Leuk-UTI-Lymphocyte-T_NK-CD4_TEM\|Leuk-UTI / Disease, Lineage and Cell Type	CFH TNRC6C PRDM8 KIAA1217 GPR171	1.11e-04	165	127	5	08285c09de16ed4f488abb655a22f54bc07968ae
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated\|Liver / Manually curated celltypes from each tissue	FAM184A CARMIL1 ZNF208 PRDM8 ZNF724	1.14e-04	166	127	5	9afa33b5ad27dc33576be592f9b22d8161366838
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CFH ITPR2 NPFFR2 KIAA1217 KRT40	1.14e-04	166	127	5	739dfbe927f409821ff23aca6e47ebe78f57e859
ToppCell	BAL-Control-cDC_6\|Control / Compartment, Disease Groups and Clusters	HNF1B ABHD17C CCDC88C PRDM8 PKD2L2	1.20e-04	168	127	5	65ec473cff748b334c0a66e33bc34a8465fe7631
ToppCell	Mild/Remission-B_naive-4\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	CARMIL1 ITPR1 ZBTB10 MACF1 VAV3	1.24e-04	169	127	5	c3a6179a64589a370108fea809b157839347759c
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PARP2 ZNF675 KIFAP3 HENMT1 DST	1.24e-04	169	127	5	665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PARP2 ZNF675 KIFAP3 HENMT1 DST	1.24e-04	169	127	5	6614c9851537e4c21b1e45ff0cc3bad07ef9d034
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFH COL12A1 TECTA FAP C3	1.34e-04	172	127	5	e37c0b5b547a7345179ab258dd2141fec7064c17
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_6\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HNF1B ABHD17C PRDM8 PKD2L2 P3H2	1.54e-04	177	127	5	3a150dcaefa342d49968b42c7cdb1fbb633adcd0
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_6\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HNF1B ABHD17C PRDM8 PKD2L2 P3H2	1.54e-04	177	127	5	c9e5820ff0bc7ad1adcfb2651713fdfc58bced56
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CFH HNF1B FHOD3 P3H2 ALPK2	1.58e-04	178	127	5	544379f5a6145429762258d426b876bb36c112f5
ToppCell	TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1\|TCGA-Adrenal / Sample_Type by Project: Shred V9	TRHDE PCLO ST8SIA3 KIFAP3 TMX3	1.62e-04	179	127	5	431e1b29015ec817f778499106d24b19cfc825ae
ToppCell	COVID-19-kidney-PCT-S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HNF1B MYO5B PCLO FHOD3 ALPK2	1.66e-04	180	127	5	358923e4228035a3e90e2957392089219e90dcd7
ToppCell	COPD-Lymphoid-T_Regulatory\|World / Disease state, Lineage and Cell class	FAM184A STAT5B CCDC88C VAV3 USP48	1.66e-04	180	127	5	51a12fbad5fa7bb12e6d616a02ff9b5141e2b063
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CFH PLCB1 C2 C3 TNNT1	1.70e-04	181	127	5	3dcb74b28f93be35ddf4de1937f7e30b25e11927
ToppCell	5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DSP FHOD3 PTPN21 ITPR2 DST	1.70e-04	181	127	5	40df0afcb6848202da54670e84f22d7c3a515d01
ToppCell	5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DSP FHOD3 PTPN21 ITPR2 DST	1.70e-04	181	127	5	2b53a65ca5616a7b9f64232c3e0b7212d1e2f063
ToppCell	5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DSP FHOD3 PTPN21 ITPR2 DST	1.70e-04	181	127	5	6aef84616e8d2faf54b7e9e6cd02f33c3066dabc
ToppCell	5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DSP FHOD3 PTPN21 ITPR2 DST	1.70e-04	181	127	5	40d3829ae4aaf81e8616c3499ff8933137fc1cc4
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CFH PLCB1 C2 C3 TNNT1	1.70e-04	181	127	5	7679a5980011d6dfb1aaca7abf678c29b6f819bb
ToppCell	Control-Epithelial_alveolar-AT_1-AT1-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B DSP OVOL2 P3H2 C3	1.75e-04	182	127	5	a95956ce4adccb34cc0c47ebfa1878ce4617904e
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B DSP OVOL2 P3H2 TNNT1	1.75e-04	182	127	5	cc79e0cc21e2fdc4ef77f052818d27b9f707aec1
ToppCell	droplet-Marrow-nan-3m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD9 TRIP11 ITSN2 MACF1 GIMAP6	1.75e-04	182	127	5	e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCell	droplet-Marrow-nan-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD9 TRIP11 ITSN2 MACF1 GIMAP6	1.75e-04	182	127	5	1710eab3037a87609d21838be2d2d29c3bc36651
ToppCell	COVID-19-kidney-Distal_Epi_Doublet_(PCT)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TRHDE HNF1B PCLO FHOD3 P3H2	1.75e-04	182	127	5	9d67717a6e13bcb54c1297a3e4e3abf4e51628a3
ToppCell	Adult-Epithelial-basal_cell\|Adult / Lineage, Cell type, age group and donor	CFH DSP FHOD3 KIAA1217 KRT40	1.79e-04	183	127	5	00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FAM184A ABHD17C ITPR1 ITPR2 PLCB1	1.79e-04	183	127	5	31ab55d5f3639f5964541d5eae23044dbda3356e
ToppCell	droplet-Spleen-nan-18m-Lymphocytic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITPR2 ITSN2 MACF1 GPR171 GIMAP6	1.79e-04	183	127	5	28cbf909424f3be4491d49832f0aca0386560814
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B DSP OVOL2 RAB3IP TNNT1	1.79e-04	183	127	5	274483009b309289e4cb84beedf6806430db6ff6
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITPR2 ITSN2 MACF1 GPR171 GIMAP6	1.79e-04	183	127	5	3fa608aa6b119869ec3280dc388dfee57160e63a
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	COL12A1 DSP PCLO PTPN21 P3H2	1.79e-04	183	127	5	6821dca076318115d360ff426eb1218cfe104063
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B DSP OVOL2 C3 TNNT1	1.84e-04	184	127	5	7cc5796557379c3d1db078c1aeda40659c6e401c
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_11\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	BEND5 KIF16B ANKRD20A3P DST P3H2	1.84e-04	184	127	5	667846c422cfa27e949a24844a305df859cb6760
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH7B SPTB FHOD3 TNNT1 ALPK2	1.89e-04	185	127	5	549eeb521c3985bff396ea0f202db21822efa51f
Disease	complement C3B measurement	CFH C3	1.61e-05	2	119	2	EFO_0020275
Disease	Hypoxic Brain Damage	ITPR1 ITPR2	1.61e-05	2	119	2	C1140716
Disease	Anoxic Encephalopathy	ITPR1 ITPR2	1.61e-05	2	119	2	C0003132
Disease	Brain Hypoxia	ITPR1 ITPR2	1.61e-05	2	119	2	C1527348
Disease	Anoxia of brain	ITPR1 ITPR2	1.61e-05	2	119	2	C0995195
Disease	wet macular degeneration	CFH C2 C3	2.25e-05	14	119	3	EFO_0004683
Disease	WAP four-disulfide core domain protein 5 measurement	CFH C2	4.83e-05	3	119	2	EFO_0803264
Disease	vesicle-associated membrane protein 8 measurement	CFH C2	4.83e-05	3	119	2	EFO_0803254
Disease	complement C3D fragment measurement	CFH C3	4.83e-05	3	119	2	EFO_0020277
Disease	B-cell lymphoma 6 protein measurement	CFH C2	4.83e-05	3	119	2	EFO_0021933
Disease	interleukin-17F measurement	CFH C2	4.83e-05	3	119	2	EFO_0021963
Disease	complement C3 measurement	CFH C3	4.83e-05	3	119	2	EFO_0004983
Disease	Age-related macular degeneration	CFH C2 C3	4.99e-05	18	119	3	cv:C0242383
Disease	cullin-9 measurement	CFH C2	9.63e-05	4	119	2	EFO_0802437
Disease	alanine aminotransferase 1 measurement	CFH C2	9.63e-05	4	119	2	EFO_0802260
Disease	n-acetylglucosamine-6-sulfatase measurement	CFH RASSF3	9.63e-05	4	119	2	EFO_0020586
Disease	atrophic macular degeneration	CFH C2 C3	1.38e-04	25	119	3	EFO_1001492
Disease	neuropsychological test	TRHDE KCNF1 FAM177B KIAA1217 PLCB1 PXYLP1	1.52e-04	197	119	6	EFO_0003926
Disease	cystatin-8 measurement	CFH C2	1.60e-04	5	119	2	EFO_0801509
Disease	ATP-dependent RNA helicase A measurement	CFH C2	1.60e-04	5	119	2	EFO_0802294
Disease	tight junction protein ZO-1 measurement	CFH C2	1.60e-04	5	119	2	EFO_0803155
Disease	hephaestin-like protein 1 measurement	CFH C2	1.60e-04	5	119	2	EFO_0802597
Disease	interferon alpha-5 measurement	CFH C2	1.60e-04	5	119	2	EFO_0802642
Disease	fibroblast growth factor 5 measurement	CFH PRDM8	1.60e-04	5	119	2	EFO_0010784
Disease	macular degeneration (is_implicated_in)	CFH C2 C3	1.74e-04	27	119	3	DOID:4448 (is_implicated_in)
Disease	v-set and transmembrane domain-containing protein 4 measurement	CFH C3	2.39e-04	6	119	2	EFO_0803247
Disease	protachykinin-1 measurement	CFH PLCB1	2.39e-04	6	119	2	EFO_0801934
Disease	Age related macular degeneration	CFH C2 C3	2.40e-04	30	119	3	C0242383
Disease	Complement deficiency disease	CFH C2 C3	3.19e-04	33	119	3	C0272242
Disease	ER membrane protein complex subunit 4 measurement	C2 C3	3.34e-04	7	119	2	EFO_0801580
Disease	CHARGE syndrome (implicated_via_orthology)	CHD9 CHD8	3.34e-04	7	119	2	DOID:0050834 (implicated_via_orthology)
Disease	regulator of G-protein signaling 8 measurement	CFH C3	3.34e-04	7	119	2	EFO_0801997
Disease	baculoviral IAP repeat-containing protein 5 measurement	CFH C2	3.34e-04	7	119	2	EFO_0020174
Disease	C-C motif chemokine 1 measurement	CFH C2	3.34e-04	7	119	2	EFO_0008041
Disease	invasive lobular carcinoma (is_marker_for)	STAT5A CTNNA1	3.34e-04	7	119	2	DOID:3457 (is_marker_for)
Disease	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 measurement	CFH C2	3.34e-04	7	119	2	EFO_0020108
Disease	stabilin-2 measurement	CFH C2	4.44e-04	8	119	2	EFO_0020752
Disease	neurexophilin-1 measurement	CFH C2	4.44e-04	8	119	2	EFO_0008244
Disease	alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 measurement	CFH C3	4.44e-04	8	119	2	EFO_0801373
Disease	beta-Ala-His dipeptidase measurement	ZNF675 ZNF681	4.44e-04	8	119	2	EFO_0008033
Disease	calcium/calmodulin-dependent protein kinase type 1D measurement	CFH C3	4.44e-04	8	119	2	EFO_0008063
Disease	atypical hemolytic-uremic syndrome (is_implicated_in)	CFH C3	4.44e-04	8	119	2	DOID:0080301 (is_implicated_in)
Disease	mean corpuscular hemoglobin concentration	ATR CARMIL1 SPTB ITPR2 OVOL2 BBS7 KIAA1217 PLCB1 MACF1 PRKDC PIBF1 DCAF12 XPO7	5.28e-04	1105	119	13	EFO_0004528
Disease	C3 glomerulopathy	CFH C3	5.70e-04	9	119	2	C4087273
Disease	Atypical hemolytic-uremic syndrome	CFH C3	5.70e-04	9	119	2	cv:C2931788
Disease	cellular retinoic acid-binding protein 1 measurement	CFH C3	5.70e-04	9	119	2	EFO_0801463
Disease	Hemolytic-uremic syndrome	CFH C3	5.70e-04	9	119	2	cv:C0019061
Disease	complement factor B measurement	CFH C2	5.70e-04	9	119	2	EFO_0008096
Disease	RNA-binding protein 24 measurement	CFH C3	5.70e-04	9	119	2	EFO_0802030
Disease	tumor necrosis factor ligand superfamily member 14 measurement	CFH C3	5.70e-04	9	119	2	EFO_0010613
Disease	Combined immunodeficiency	STAT5A STAT5B PRKDC	6.10e-04	41	119	3	C0494261
Disease	DNA-directed RNA polymerases I and III subunit RPAC1 measurement	CFH C3	7.11e-04	10	119	2	EFO_0801535
Disease	DNA repair protein rad51 homolog 1 measurement	CFH C2	7.11e-04	10	119	2	EFO_0020330
Disease	OCIA domain-containing protein 1 measurement	CFH C3	7.11e-04	10	119	2	EFO_0008252
Disease	Atypical Hemolytic Uremic Syndrome	CFH C3	7.11e-04	10	119	2	C2931788
Disease	stromal interaction molecule 1 measurement	CFH C2	7.11e-04	10	119	2	EFO_0802093
Disease	heart rate variability measurement, response to antipsychotic drug	COL12A1 ATAD3B HS6ST1	8.55e-04	46	119	3	EFO_0008003, GO_0097332
Disease	glycerol-3-phosphate dehydrogenase 1-like protein measurement	CFH C2	8.66e-04	11	119	2	EFO_0801640
Disease	cryptic phenotype measurement	ABHD17C PRDM8 PLCB1	9.11e-04	47	119	3	EFO_0021487
Disease	platelet component distribution width	NUP210L SEPTIN9 CARMIL1 KIF16B P3H2 ZBTB10 PLCB1 MACF1 DCAF12 XPO7	9.86e-04	755	119	10	EFO_0007984
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	ITPR1 ITPR2	1.04e-03	12	119	2	DOID:1441 (implicated_via_orthology)
Disease	oncostatin-M measurement	CFH C3	1.04e-03	12	119	2	EFO_0010792
Disease	tyrosine-protein kinase ZAP-70 measurement	CFH C3	1.04e-03	12	119	2	EFO_0020833
Disease	tyrosine-protein phosphatase non-receptor type 1 measurement	CFH C2	1.22e-03	13	119	2	EFO_0020834
Disease	chromosome-type aberration frequency	UTP6 SUZ12	1.42e-03	14	119	2	EFO_0009861
Disease	adverse effect, response to xenobiotic stimulus	FHOD3 KIFAP3 PLCB1	1.76e-03	59	119	3	EFO_0009658, GO_0009410
Disease	Antibody Deficiency Syndrome	CFH C3	2.11e-03	17	119	2	C0003257
Disease	congenital heart disease (implicated_via_orthology)	CHD9 CHD8 ITPR1	2.76e-03	69	119	3	DOID:1682 (implicated_via_orthology)
Disease	serum alanine aminotransferase measurement	CFH HNF1B COL12A1 MYH7B SEPTIN9 PCLO KIF16B CCDC102B USP48 DCAF12	2.77e-03	869	119	10	EFO_0004735
Disease	BRCAX breast cancer	ITPR2 DCAF12	2.92e-03	20	119	2	EFO_0009443
Disease	attention function measurement	ITPR1 DST P3H2 KIAA1217	3.09e-03	148	119	4	EFO_0007636
Disease	COVID-19 (is_implicated_in)	CFH C3	3.22e-03	21	119	2	DOID:0080600 (is_implicated_in)
Disease	amyloid-beta measurement	HNF1B CCDC146 WDR75 KIAA1217 PLCB1 PRKDC	3.23e-03	355	119	6	EFO_0005194
Disease	endometriosis	COL12A1 BEND5 ABHD17C PLCB1 C2	3.62e-03	252	119	5	EFO_0001065
Disease	urate measurement, bone density	CARMIL1 ITPR1 ITPR2 CEP70 PLCB1 C2 CTNNA1 PRKDC	3.67e-03	619	119	8	EFO_0003923, EFO_0004531
Disease	Immunologic Deficiency Syndromes	CFH C3	3.86e-03	23	119	2	C0021051
Disease	atrial fibrillation	ABHD17C ITPR2 PRDM8 PKD2L2 RAB3IP XPO7	4.01e-03	371	119	6	EFO_0000275

Protein segments in the cluster

Peptide	Gene	Start	Entry
DAQRNYNLKIIYNAL	TRHDE	226	Q9UKU6
ALYEELLRNYQQQQE	BEND5	181	Q7L4P6
HLQYKVLQERENYQQ	BBS7	351	Q8IWZ6
QLQYSQSLIEKDQYR	CARD10	406	Q9BWT7
LSHEYKNRNQLREYQ	CHD8	801	Q9HCK8
HRQVYKNLQEINAYI	CYP2B6	231	P20813
IQRNYKLAAQECYVQ	ALPK2	1971	Q86TB3
EIRAVLYNYRQNQEL	C3	846	P01024
LYNYRQNQELKVRVE	C3	851	P01024
LCRNLDNLIQQYKYE	DOP1A	1686	Q5JWR5
YQCQNLYQLEGNKRI	CFH	1136	P08603
RTQQEYYERELKNLQ	FAM184A	451	Q8NB25
RLQYKERQLQYLLQN	KIF16B	901	Q96L93
VQEEKYYRVRLNSQN	NPFFR2	286	Q9Y5X5
YIRYIQQGLVKQQDV	RAB3IP	436	Q96QF0
EQLQNLKRRYTAYRQ	RASSF3	211	Q86WH2
QQELQEYQNKLIYLV	ITSN2	541	Q9NZM3
RETYNTQQLALEQLY	ITSN2	651	Q9NZM3
RHSQQDYRKNQEYIA	ITPR2	561	Q14571
FNNNKYYLIQLLEDD	PARP2	126	Q9UGN5
DICTYQRLQQRLYLQ	ANKAR	281	Q7Z5J8
QLAVLLQLYDYQLEQ	RELCH	806	Q9P260
YVKRNLNSRYNLNIK	PAN2	921	Q504Q3
YQRYFNTIEDLQQKI	KRT40	136	Q6A162
LTQDLVQENYLEYRQ	MAGEA12	246	P43365
QTDYRIFELNKRLQN	LDB1	66	Q86U70
RHSQQDYRKNQEYIA	ITPR1	561	Q14643
YYQADQLVQRVAKLR	DST	456	Q03001
LNINQKRNDYLDIYA	C2	396	P06681
LVRNIKTYYQEVLQQ	CCDC88C	81	Q9P219
QKLQQYKRFVENYRR	DUOX2	1026	Q9NRD8
QYVLNEFYRIQNKKS	FAM177B	101	A6PVY3
QKSQNRLLATLYENY	MYH7B	656	A7E2Y1
QLEEQKIRQIYQYNY	PCLO	3306	Q9Y6V0
LVIRQLYRNKDNENY	GPR171	201	O14626
YNYLQRAYIKLNQLE	P3H2	151	Q8IVL5
QQQYAYKQRRDKLYV	OVOL2	201	Q9BRP0
QYIQYLQRNIDAAKA	MEIOSIN	111	C9JSJ3
LYRNQNYNKLQHVQT	GPR75	271	O95800
AKDLFQQRYQYKRQL	HS6ST1	351	O60243
QQRYQYKRQLERREQ	HS6ST1	356	O60243
LLNLRNLYLQYNQVS	LRRC70	131	Q7Z2Q7
QLQVDLQILRDENYY	MACF1	486	Q9UPN3
LQQEITRYQYYLQLK	PTPN21	111	Q16825
AFRYQQELNYLKAEN	ANKRD20A3P	571	Q5VUR7
LRKRVRQYLDQQQYQ	CDC16	6	Q13042
LNVNRREILINNFKY	ATR	1021	Q13535
SRDYKNGNQLREYQL	CHD9	851	Q3L8U1
LYRQRYQFVKNLVDQ	HENMT1	31	Q5T8I9
YINNQLENLVQEYRA	IFT57	306	Q9NWB7
RQLRYEVDQALNYFQ	KLHL15	246	Q96M94
AYKANRDLIYKQLQQ	CTNNA1	236	P35221
KYNQQQALIDQRYFQ	CEP70	336	Q8NHQ1
EFNLNQYYQRDELLA	COL12A1	191	Q99715
LVYYLKNREVRLQNE	DCAF12	46	Q5T6F0
LEKQIKQLRNYRDNY	DSP	881	P15924
DQNYQNYILRALGQI	FHOD3	161	Q2V2M9
NDIELYAQYLERLKQ	ABHD17C	306	Q6PCB6
LLQGYQQENERLYNQ	CEP162	716	Q5TB80
QYFYELQDNLEKLLQ	MAST2	381	Q6P0Q8
ETRKYLQEQAYRLQQ	CARMIL1	666	Q5VZK9
GQDFNQRLLQYLYKQ	HSPA13	256	P48723
NEYEQLNYAKQLKER	FBXL5	101	Q9UKA1
YKLNRQYQANIAELT	CCDC102B	431	Q68D86
ALVRYNQQNDNYRLK	GARNL3	331	Q5VVW2
LNEVEQLLYYLQNRR	KIFAP3	86	Q92845
KRKQNQYIYRIQCLD	NUP210L	711	Q5VU65
ASQQILYQAYDRQKN	HNF1B	241	P35680
EDQLQDYRKNNTYLV	GOLM2	141	Q6P4E1
NYVQYEINLLELIQR	UTP6	56	Q9NYH9
LNQLYQLQLAYQRLQ	TNRC6C	1151	Q9HCJ0
QQKYEINVLYNRISH	TNNT1	246	P13805
VEYINKYRQLEAQEL	TDRD9	81	Q8NDG6
YQYTQQNFRLKELQE	GIMAP6	236	Q6P9H5
QNLEAYIKNGQLFYR	PRDM8	101	Q9NQV8
QYEKYLQEEVNINRK	SEPTIN9	386	Q9UHD8
RNVYYELNDVRNIQD	KIAA1217	241	Q5T5P2
EKYYNNLLTIQDRNN	ST8SIA3	216	O43173
YFIIQYQESLRIQAQ	STAT5B	171	P51692
QQYQDAANNLREDYK	PDIA4	321	P13667
NQYLEKEQRRQYLLR	PXYLP1	251	Q8TE99
YFIIQYQESLRIQAQ	STAT5A	171	P42229
QLLKYQNEYNAVKER	CCDC146	126	Q8IYE0
QYQDKLARQRYEDQL	ATAD3B	131	Q5T9A4
ERNRQYQKLQGLYDS	CCNB1IP1	166	Q9NPC3
LYRNNLQKYIEIYVQ	CLTC	791	Q00610
LQYIKITRQQYQNGL	CNNM4	706	Q6P4Q7
KLAYVYQNNIYLKQR	FAP	161	Q12884
YFYINEEQILINDRN	TECTA	1546	O75443
NQQYFLLDRQIKNVE	TMX3	316	Q96JJ7
QNLYRNVMLENYRNL	ZNF99	26	A8MXY4
ELFRYNSNLIKYQQN	ZNF749	231	O43361
QNLYRNVMLENYRNL	ZNF724	26	A8MTY0
QQAAYYAQERKQLAK	TRAPPC11	351	Q7Z392
DKQLYNLDIIQQEYI	WDR75	366	Q8IWA0
IYLKENYLQNRQFQQ	TRPM2	1126	O94759
ENRQKLRIFYQFLYN	SUZ12	421	Q15022
KNLYQDVMLENYRNL	ZNF267	26	Q14586
KQLIQQGDYRQENYD	PIBF1	251	Q8WXW3
QNLYRNVMLENYRNL	ZNF728	26	P0DKX0
YRQQYEEQQKRQSLE	ZNF609	1001	O15014
QEKNFLINYYNRIKD	SNX5	211	Q9Y5X3
RLQRLRDANEAQQYY	SPTB	1576	P11277
QEAQLYKEEGNQRYR	TTC9C	6	Q8N5M4
NNQQLYNLKNSSRIY	PKD2L2	106	Q9NZM6
KQQQQLLNLRQEQYY	PLCB1	1011	Q9NQ66
LLNLRQEQYYSEKYQ	PLCB1	1016	Q9NQ66
KYTNNLQGDEQRLYE	TOP3A	421	Q13472
LLQDDVDRAKYYIQN	PRKDC	3091	P78527
NAQDHLLYRVNKYVN	TLCD1	161	Q96CP7
RNLYKNVILENYRNL	ZNF675	26	Q8TD23
QNLYRNVMLENYRNL	ZNF43	26	P17038
QNLYRNVMLENYRNL	ZNF708	26	P17019
KNLYRNVMLENYRNL	ZNF726	26	A6NNF4
QQDLYRKVMLENYRN	ZNF430	56	Q9H8G1
QVEQIQKEQDYQRYR	TMED4	166	Q7Z7H5
QNLYRNVMLENYRNL	ZNF208	26	O43345
YLQQQLQAYAMEREK	TRIP11	1086	Q15643
DSYRNEIAYLNKLQQ	TTK	566	P33981
QNLYRNVMLENYRNL	ZNF681	26	Q96N22
EQRIDIRNYVLNYLA	XPO7	81	Q9UIA9
QNLYRNVMLENYRNL	ZNF429	26	Q86V71
QVILNKYVERIQNYA	TTC37	966	Q6PGP7
YCYQLLRQLNEQRKK	ZBTB10	346	Q96DT7
YRNLQIAKNSYNDAL	TRPM8	506	Q7Z2W7
NLYYNNRTVQAIVEL	UBR4	3591	Q5T4S7
HQNYIAYQKQVIRRS	USP48	921	Q86UV5
DQNLYQVFINYKERL	VAV3	261	Q9UKW4
QKNLYREVMLENYRN	ZNF554	66	Q86TJ5
INNFVRYYNKQRVLE	KCNF1	406	Q9H3M0
NIQIRYQKESQVYLL	LCP2	471	Q13094
RYQNLVKEYSQLEQR	MYO5B	1066	Q9ULV0